-
Mashup Score: 5Home - Precision Oncology - 2 hour(s) ago
This EACCME-accredited webinar will cover chronic kidney disease in cardio-renal-metabolic patients and management in primary care.
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0Muir of Dinnet: Behaviour warning issued to beauty spot visitors - 2 hour(s) ago
NatureScot says”unacceptable damage” has been caused at the Muir of Dinnet National Nature Reserve.
Source: www.bbc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Association between low-density lipoprotein cholesterol levels and serum uric acid to serum creatinine ratio in Chinese male gout patients - 2 hour(s) ago
Scientific Reports – Association between low-density lipoprotein cholesterol levels and serum uric acid to serum creatinine ratio in Chinese male gout patients
Source: www.nature.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
‘Colouring the Mind: Racism and Mental Health’ is a new In Conversation mini-series that will explore how racism affects mental health, with a particular focus on racism in the mental health system and racism in the mental health concept. In this episode, Malaika Okundi and Jessica O’Logbon focus on racism in the mental health system and discuss what the mental health system is, how people of colour are treated in the mental health system, and where we can go from here.
Source: www.acamh.orgCategories: General Medicine News, PediatricsTweet
-
Mashup Score: 0Cholesterol Denialism is Pseudoscience - 2 hour(s) ago
Early research on cholesterol’s role in atherosclerosis warranted skepticism, but there is no place for modern-day doubters given the supportive evidence for lipid lowering, writes Chris Labos, MD.
Source: www.medscape.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
The STOP (Standardized Treatment of Pulmonary Exacerbations) clinical studies were first described in 2017 (1 – 4). Initially designed as an observational study, they have evolved into a series of interventional studies designed to develop the best evidence base to inform pulmonary exacerbation (PEx) management, with the ultimate goal of using these data to ensure the best possible outcomes for affected persons with cystic fibrosis (pwCF) (2). STOP2, in particular, was a randomized trial primarily
Source: www.atsjournals.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 0Research papers and PhDs | British Society for Rheumatology - 2 hour(s) ago
This webinar focuses on research/academic work.
Source: www.rheumatology.org.ukCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 8AcuteCVDays - 2 hour(s) ago
AcuteCVDays, brought to you by the Association for Acute Cardiovascular Care (ACVC), facilitates learning and discussing potential differences between North America and Europe in the management and treatment of acute myocardial infarction. Every week, you can expect clinical cases, expert opinions, polls and a selection of relevant resources on acute myocardial infarction, covering best practices from both sides of the Atlantic.
Source: www.escardio.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 5Sickle cell: NICE approves voxelotor after initially rejecting it over uncertain evidence - 2 hour(s) ago
Up to 4000 patients could be offered voxelotor (Oxbryta), a treatment for sickle cell disease which may reduce the need for blood transfusions, after the drug was recommended by the UK National Institute for Health and Care Excellence (NICE) in final draft guidance.1 Voxelotor, a once daily pill, will now be available on the NHS in England for people aged 12 and older and for whom hydroxycarbamide alone is insufficient or where the patient cannot take hydroxycarbamide. NICE has said clinical …
Source: www.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The NYPD’s response to the disorder at Columbia and CCNY’s campuses Tuesday night brought a strange feeling to me, one I haven’t felt for four years: pride.
Source: nypost.comCategories: General Medicine News, Partners & KOLsTweet
A warm invitation to Biomarker Positive Disease: A personalised approached to selecting Targeted Tx in #LungCancer 🫁& Beyond by our collaborators at @SpringerIME Link: https://t.co/l8smhZsQO1 with Experts: @peters_solange 🇨🇭@DrJaimeLaurel 🇺🇸 and @HendriksLizza 🇳🇱 https://t.co/XHOJ1MYUob